Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion

Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion

Bibliographic Details
Main Authors:	Stein, E, Shepherd, J, Barter, P, Hobbs, R
Format:	Journal article
Published:	2003

Similar Items

Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion
by: Davidson, M, et al.
Published: (2003)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
by: Krisztián Csomó, et al.
Published: (2022-07-01)

Apolipoprotein E gene polymorphisms: a relationship with the risk of coronary artery disease and the effectiveness of lipid-lowering therapy with rosuvastatin
by: M. I. Churilin, et al.
Published: (2020-03-01)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
Published: (2013-01-01)

Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model
by: Kaya Hacer Kayhan, et al.
Published: (2024-03-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
by: Sandeep Joshi, et al.
Published: (2017-12-01)

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
by: Langping Zhou, et al.
Published: (2023-06-01)

Atorvastatin and simvastatin in clinical management of high-risk patients
by: S. A. Shalnova, et al.
Published: (2009-02-01)

Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting: A Double-blind Randomized Comparative Trial
by: Zahra Samadifar, et al.
Published: (2023-04-01)

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
by: Berne Christian, et al.
Published: (2005-06-01)

Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease
by: Stanislav Kononov, et al.
Published: (2023-06-01)

THE INFLUENCE OF ATORVASTATIN AND ROSUVASTATIN IN ATHEROSCLEROSIS ON THE PARAMETERS OF CELLULAR IMMUNITY AND IN VITRO LEUCOCYTE ACTIVATION
by: A. Yu. Filatova, et al.
Published: (2018-09-01)

Optimization of RPLC Conditions for Quantitative Analysis of Atorvastatin and Rosuvastatin in Pharmaceutical Dosage Form
by: Zehra ÜSTÜN, et al.
Published: (2016-05-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
by: Esraa M. Adel, et al.
Published: (2022-08-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

THE EFFECTS OF SIMVASTATIN, ROSUVASTATIN, AND FENOFIBRATE ON THE BODY WEIGHT AND LIPID PROFILES OF FEMALE RATS TREATED WITH ORAL CONTRACEPTIVES AND A HIGH-FAT DIET
by: Dwi Anggara Putri, et al.
Published: (2022-09-01)

Effects of simvastatin on plasma lipoproteins and response to arterial injury in wild-type and apolipoprotein-E-deficient mice.
by: Choudhury, R, et al.
Published: (2004)

Efeitos da atorvastatina, fluvastatina, pravastatina e simvastatina sobre a função endotelial, a peroxidação lipídica e a aterosclerose aórtica em coelhos hipercolesterolêmicos Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits
by: Paulo Afonso Ribeiro Jorge, et al.
Published: (2005-04-01)

Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome
by: A. A. Yalymov, et al.
Published: (1970-01-01)

SERUM LEVEL OF LIPIDS, APOLIPOPROTEINS AND VITAMIN D IN CHILDREN AT HIGH RISK OF CORONARY ARTERY DISEASE
by: M BASHTAM, et al.
Published: (2002-06-01)

Comparative investigation of antitumoral effectiveness of Rho-kinase inhibitor Y-27632, pravastatin and atorvastatin in anaplastic thyroid cancer cell culture
by: Erdinc Nayir, et al.
Published: (2017-07-01)

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004)

ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING
by: A. V. Panov, et al.
Published: (2017-07-01)

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
by: Reid, I, et al.
Published: (2001)

Effects of simvastatin on the response to arterial injury in wild-type (WT) and apolipoprotein E-deficient (ApoE0) mice
by: Choudhury, R, et al.
Published: (2002)

Association of apolipoprotein E genotypes with lipid levels and coronary risk.
by: Bennet, A, et al.
Published: (2007)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

Atorvastatin in patients with coronary artery disease and left ventricular systolic dysfunction
by: E. V. Filippov, et al.
Published: (2019-10-01)

Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
by: N. B. Amirov, et al.
Published: (1970-01-01)

Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
by: Wei-Ting Liu, et al.
Published: (2020-11-01)

Comparison of efficiency between Rosuvastatin and Atorvastatin in reducing low-density lipoprotein (LDL-C) in patients with diabetes mellitus
by: Saad Ahmed Khokhar, et al.
Published: (2022-06-01)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
by: Samad Golshani, et al.
Published: (2022-01-01)

Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
by: Betteridge, D, et al.
Published: (1992)

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2000)

Pravastatin therapy and the risk of stroke.
by: White, H, et al.
Published: (2000)

Association of Apolipoprotein B and Triglyceride Levels with Coronary Artery Disease
by: Hunain Habib, et al.
Published: (2022-11-01)

Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease
by: Clarke, R, et al.
Published: (2023)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Polymorphisms of the apolipoprotein E gene affect response to atorvastatin therapy in acute ischemic stroke
by: QianQian Bi, et al.
Published: (2022-11-01)